Laddar...
Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics
The remarkable global development of disease-modifying therapies (DMTs) specific for multiple sclerosis (MS) has significantly reduced the frequency of relapse, slowed the progression of disability, and improved the quality of life in patients with MS. With increasing numbers of approved DMTs, neuro...
Sparad:
| I publikationen: | Neurosci Bull |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5563727/ https://ncbi.nlm.nih.gov/pubmed/26480875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12264-015-1560-6 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|